58
认认认认认认认认认认 认认认认认 认认认认认认认认

认识艾滋病防治与照护

Embed Size (px)

DESCRIPTION

认识艾滋病防治与照护. 接纳与关怀. 杨依纯个案管理师. 人因对疾病的不了解, 因而产生恐惧与害怕. 希望藉由此次分享,可让大家对艾滋病有更进一层认识. 总感染人数(至 2011 年)超过 3,400 万人. 全球艾滋病感染统计. 非洲 70% 东南亚 15% 亚洲是本世纪下一个严重的疫区. 数据源:联合国艾滋病规划署 2012 年 11 月. 中国大陆艾滋病流行状况 (1). - PowerPoint PPT Presentation

Citation preview

  • 70% 15% 20113,400201211

  • (1) 198561989172

  • (2)19852006831HIV18064039993976731()HIV( )

  • ?HIV Epidemic StatusChina?

  • 20068HIV(19986)HIV

  • 30691

  • 2006555295737562004

  • 1981- First report in MMWR 1981, PCP in 5homosexual menin Los Angeles1982- (Gay-related immunodificiency syndrome, GRID)1983- HIV1984- 1985- HIV serological test was developed1987- AZT was approved by FDA for AIDS : 1984121988- HIVGuidelines for diagnosis and treatment of HIV/AIDS

  • 1990- 1991- 12171996- HAART (highly active antiretroviral therapy)1997.04- HAART2005- Anti-HIV/2006-

    Guidelines for diagnosis and treatment of HIV/AIDS

  • 84'85'86'87'88'89'90'91'92'93'94'95'96'97'98'99'00'01'02'03'04'05'

    1000150020002500300035004000

    HIV-1, HIV-1/2 2005 5000

  • / (Acquired Immunodeficiency Syndrome, AIDS) HIVHIV

  • /Infectious agent HIVHuman Immunodeficiency VirusHIV-1HIV-2HIV-1HIV-2HIV-190%10-12HIV-2

  • ELISA (Enzyme-linked immunosorbant assay) (Western blot)ELISAELISA

  • HIVHIVCD4

  • HIVAIDSCD4 200/ulPVL 10copies/mlHAART

  • : () (10%)(3)

  • Mode of transmission

  • 71.49%0.12%1. 48% 26.91%71.49%26.91%0.12%1.48%43.08%19.92%8.49%26.91%0.12%2005: = 10:1....

  • 90 %0.67%0.3%0.09%

  • HIV

    HIV 1 2 10 20 13 100 1 20

  • 0%20%40%60%80%100%(
  • :25-40%:60-75%:15-25%Guidelines for diagnosis and treatment of HIV/AIDS2%

  • -

    /

  • , , , , , , , , , , , , , , , , Guidelines for diagnosis and treatment of HIV/AIDS

  • www.themegallery.com

  • -HAART()(highly active antiretroviral therapy)

    3 main categories1 NNRTI+2NRTIs 1 PI+2NRTIs1 II+2NRTI

    integrase inhibitors(II)Protease Inhibitors(PI) Nucleoside Reverse Transcriptase Inhibitors(NRTI)Non-Nucleoside Reverse Transcriptase Inhibitors(NNRTI)Raltegravir(isentress)nelfinavirzalcitabine,ddCnevirapineSaquinavirstavudine, D4tefavirenz Indinavirdidanosine, ddlritonavirlamivudine,3TClopinavir/ritonavirZidovudine+AZTatazanavirAbacavir+ ABCAZT + 3TC 3TC + abacavir Tenofovir

  • - HAART -

    4-899%(

  • 80%51%37%54%44%54%32%68%49%+46%

  • /

  • standard precautions*

  • . 0.60.6

  • 24-48 72CD4 (HBsAgAnti- HCVVDRL-pt Anti-HIV)4 HIV6 3 6 HCV

  • HIV

  • .

  • */ / -/

    -//-

  • ////

    /

  • ()

  • /

  • HAART(HIV)

  • Q&A

  • QA (HIV)

  • Q: A

  • Q:A:

  • **

    *****?Acquired Immuno Deficiency Syndrome AIDSHIV***** :